Jonathan G. Sham

1.1k total citations
31 papers, 865 citations indexed

About

Jonathan G. Sham is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Jonathan G. Sham has authored 31 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Jonathan G. Sham's work include Pancreatic and Hepatic Oncology Research (12 papers), Neuroendocrine Tumor Research Advances (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Jonathan G. Sham is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Neuroendocrine Tumor Research Advances (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Jonathan G. Sham collaborates with scholars based in United States, Canada and Chile. Jonathan G. Sham's co-authors include Miqin Zhang, Forrest M. Kievit, James O. Park, Raymond S. Yeung, Venu G. Pillarisetty, Stephen J. Florczyk, Soumen Jana, Kui Wang, David L. Wood and Zachary R. Stephen and has published in prestigious journals such as ACS Nano, PLoS ONE and Biomaterials.

In The Last Decade

Jonathan G. Sham

27 papers receiving 857 citations

Peers

Countries citing papers authored by Jonathan G. Sham

Since Specialization

Citations

This map shows the geographic impact of Jonathan G. Sham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan G. Sham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan G. Sham more than expected).

Fields of papers citing papers by Jonathan G. Sham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan G. Sham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan G. Sham. The network helps show where Jonathan G. Sham may publish in the future.

Co-authorship network of co-authors of Jonathan G. Sham

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan G. Sham. A scholar is included among the top collaborators of Jonathan G. Sham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan G. Sham. Jonathan G. Sham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Financial Hardship After Surgical Procedures	JAMA Surgery	Alexandra Hernández, Nina M. Clark et al.	0
2	Somatostatin Analogs for Preventing Postoperative Pancreatic Fistula: Past Evidence Reveals New Opportunities	Annals of Surgical Oncology	Venu G. Pillarisetty, Jonathan G. Sham et al.	0
3	Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline ATM Mutated Pancreatic Ductal Adenocarcinoma	Advances in Radiation Oncology	Rachael A. Safyan, Smith Apisarnthanarax et al.	0
4	Prophylactic somatostatin analogs for postoperative pancreatic fistulas: a cross-sectional survey of AHPBA surgeons	HPB	Jonathan G. Sham et al.	1
5	Evaluating surgeon communication of pancreatic cancer prognosis using the VitalTalk ADAPT framework	Journal of Surgical Oncology	James O. Park, Venu G. Pillarisetty et al.	3
6	A phase II trial of lanreotide for the prevention of postoperative pancreatic fistula	HPB	Venu G. Pillarisetty, Arezou Abbasi et al.	10
7	Lanreotide for the Prevention of Postoperative Pancreatic Fistula: Phase Ii Clinical Trial Results	HPB	Arezou Abbasi, Jonathan G. Sham et al.	1
8	Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers	Annals of Surgical Oncology	Nina M. Clark, Emma A. Roberts et al.	8
9	IWATE criteria are associated with perioperative outcomes in robotic hepatectomy: a retrospective review of 225 resections	Surgical Endoscopy	Kevin P. Labadie, Sara K. Daniel et al.	24
10	Glypican-3–Targeted ²²⁷Th α-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma	Journal of Nuclear Medicine	Kevin P. Labadie, Donald K. Hamlin et al.	20
11	Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma	Scientific Reports	Kevin P. Labadie, Andrew D. Ludwig et al.	14
12	Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for Everybody	Annals of Surgical Oncology	Jonathan G. Sham et al.	1
13	Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective	The Lancet. Gastroenterology & hepatology	Aisling Barry, Smith Apisarnthanarax et al.	27
14	Analysis of recurrence after the resection of pancreatic neuroendocrine tumors	Journal of Surgical Oncology	Konstantinos Chouliaras, Naeem A. Newman et al.	15
15	Genomics of Peritoneal Malignancies	Surgical Oncology Clinics of North America	Enusha Karunasena, Jonathan G. Sham et al.	10
16	Efficacy and cost of robotic hepatectomy: is the robot cost-prohibitive?	Journal of Robotic Surgery	Jonathan G. Sham, Morgan K. Richards et al.	66
17	Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ‐irradiation	Molecular Oncology	Forrest M. Kievit, Zachary R. Stephen et al.	53
18	A Large Animal Survival Model to Evaluate Bariatric Surgery Mechanisms	Surgical Science	Vlad V. Simianu, Jonathan G. Sham et al.	3
19	Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment	PLoS ONE	Kendall C. Shibuya, Vikas Goel et al.	99
20	Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM	Biomaterials	Stephen J. Florczyk, Kui Wang et al.	186

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact